Literature DB >> 25602755

Role of hexokinase-1 in the survival of HIV-1-infected macrophages.

Satarupa Sen1, Rafal Kaminiski, Satish Deshmane, Dianne Langford, Kamel Khalili, Shohreh Amini, Prasun K Datta.   

Abstract

Viruses have developed various strategies to protect infected cells from apoptosis. HIV-1 infected macrophages are long-lived and considered reservoirs for HIV-1. One significant deciding factor between cell survival and cell death is glucose metabolism. We hypothesized that HIV-1 protects infected macrophages from apoptosis in part by modulating the host glycolytic pathway specifically by regulating hexokinase-1 (HK-1) an enzyme that converts glucose to glucose-6-phosphate. Therefore, we analyzed the regulation of HK-1 in HIV-1 infected PBMCs, and in a chronically HIV-1 infected monocyte-like cell line, U1. Our results demonstrate that HIV-1 induces a robust increase in HK-1 expression. Surprisingly, hexokinase enzymatic activity was significantly inhibited in HIV-1 infected PBMCs and in PMA differentiated U1 cells. Interestingly, we observed increased levels of mitochondria-bound HK-1 in PMA induced U1 cells and in the HIV-1 accessory protein, viral protein R (Vpr) transduced U937 cell derived macrophages. Dissociation of HK-1 from mitochondria in U1 cells using a pharmacological agent, clotrimazole (CTZ) induced mitochondrial membrane depolarization and caspase-3/7 mediated apoptosis. Dissociation of HK-1 from mitochondria in Vpr transduced U937 also activated caspase-3/7 activity. These observations indicate that HK-1 plays a non-metabolic role in HIV-1 infected macrophages by binding to mitochondria thereby maintaining mitochondrial integrity. These results suggest that targeting the interaction of HK-1 with the mitochondria to induce apoptosis in persistently infected macrophages may prove beneficial in purging the macrophage HIV reservoir.

Entities:  

Keywords:  COXIV, Cytochrome c oxidase subunit IV; CTZ, Clotrimazole; G-6-P, glucose-6-phosphate; G6PD, glucose-6-phosphate dehydrogenase; HIV-1; HK-1, Hexokinase-1; M-CSF, macrophage colony-stimulating factor; OMM, outer mitochondrial membrane; VDAC, voltage-dependent anion channel; Vpr, viral protein R; apoptosis, glucose metabolism; cART, combination antiretroviral therapy; hexokinase; macrophage; mitochondria

Mesh:

Substances:

Year:  2015        PMID: 25602755      PMCID: PMC4612415          DOI: 10.1080/15384101.2015.1006971

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  50 in total

1.  Mitochondrial binding of hexokinase II inhibits Bax-induced cytochrome c release and apoptosis.

Authors:  John G Pastorino; Nataly Shulga; Jan B Hoek
Journal:  J Biol Chem       Date:  2001-12-18       Impact factor: 5.157

2.  Bcl-2 upregulation by HIV-1 Tat during infection of primary human macrophages in culture.

Authors:  Mingjie Zhang; Xingxiang Li; Xiaowu Pang; Lina Ding; Owen Wood; Kathleen A Clouse; Indira Hewlett; Andrew I Dayton
Journal:  J Biomed Sci       Date:  2002 Mar-Apr       Impact factor: 8.410

3.  IkappaB kinase-dependent chronic activation of NF-kappaB is necessary for p21(WAF1/Cip1) inhibition of differentiation-induced apoptosis of monocytes.

Authors:  K N Pennington; J A Taylor; G D Bren; C V Paya
Journal:  Mol Cell Biol       Date:  2001-03       Impact factor: 4.272

Review 4.  The permeability transition pore complex: another view.

Authors:  Andrew P Halestrap; Gavin P McStay; Samantha J Clarke
Journal:  Biochimie       Date:  2002 Feb-Mar       Impact factor: 4.079

5.  Establishment of persistent infection with HIV-1 abrogates the caspase-3-dependent apoptotic signaling pathway in U937 cells.

Authors:  Y Tanaka; M Kameoka; K Ota; A Itaya; K Ikuta; K Yoshihara
Journal:  Exp Cell Res       Date:  1999-03-15       Impact factor: 3.905

6.  Elevated expression of hexokinase II protects human lung epithelial-like A549 cells against oxidative injury.

Authors:  Aftab Ahmad; Shama Ahmad; B Kelly Schneider; Corrie B Allen; Ling-Yi Chang; Carl W White
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2002-09       Impact factor: 5.464

Review 7.  Regulation of hexokinase binding to VDAC.

Authors:  John G Pastorino; Jan B Hoek
Journal:  J Bioenerg Biomembr       Date:  2008-06       Impact factor: 2.945

Review 8.  Isozymes of mammalian hexokinase: structure, subcellular localization and metabolic function.

Authors:  John E Wilson
Journal:  J Exp Biol       Date:  2003-06       Impact factor: 3.312

Review 9.  HIV-associated neuropathogenesis: a systems biology perspective for modeling and therapy.

Authors:  Susanna L Lamers; Gary B Fogel; David J Nolan; Michael S McGrath; Marco Salemi
Journal:  Biosystems       Date:  2014-04-13       Impact factor: 1.973

Review 10.  HIV-1 latency in monocytes/macrophages.

Authors:  Amit Kumar; Wasim Abbas; Georges Herbein
Journal:  Viruses       Date:  2014-04-22       Impact factor: 5.048

View more
  26 in total

1.  Non-Metabolic Role of PKM2 in Regulation of the HIV-1 LTR.

Authors:  Satarupa Sen; Satish L Deshmane; Rafal Kaminski; Shohreh Amini; Prasun K Datta
Journal:  J Cell Physiol       Date:  2016-06-10       Impact factor: 6.384

2.  Glutamate metabolism in HIV-1 infected macrophages: Role of HIV-1 Vpr.

Authors:  Prasun K Datta; Satish Deshmane; Kamel Khalili; Salim Merali; John C Gordon; Chiara Fecchio; Carlos A Barrero
Journal:  Cell Cycle       Date:  2016-05-31       Impact factor: 4.534

3.  Preferential Destruction of Interstitial Macrophages over Alveolar Macrophages as a Cause of Pulmonary Disease in Simian Immunodeficiency Virus-Infected Rhesus Macaques.

Authors:  Yanhui Cai; Chie Sugimoto; Mariluz Arainga; Cecily C Midkiff; David Xianhong Liu; Xavier Alvarez; Andrew A Lackner; Woong-Ki Kim; Elizabeth S Didier; Marcelo J Kuroda
Journal:  J Immunol       Date:  2015-10-02       Impact factor: 5.422

4.  Exosomes from uninfected cells activate transcription of latent HIV-1.

Authors:  Robert A Barclay; Angela Schwab; Catherine DeMarino; Yao Akpamagbo; Benjamin Lepene; Seble Kassaye; Sergey Iordanskiy; Fatah Kashanchi
Journal:  J Biol Chem       Date:  2017-05-23       Impact factor: 5.157

5.  Hexokinase 1 cellular localization regulates the metabolic fate of glucose.

Authors:  Adam De Jesus; Farnaz Keyhani-Nejad; Carolina M Pusec; Lauren Goodman; Justin A Geier; Joshua S Stoolman; Paulina J Stanczyk; Tivoli Nguyen; Kai Xu; Krishna V Suresh; Yihan Chen; Arianne E Rodriguez; Jason S Shapiro; Hsiang-Chun Chang; Chunlei Chen; Kriti P Shah; Issam Ben-Sahra; Brian T Layden; Navdeep S Chandel; Samuel E Weinberg; Hossein Ardehali
Journal:  Mol Cell       Date:  2022-03-18       Impact factor: 17.970

6.  Trypanosoma brucei brucei Induced Hypoglycaemia Depletes Hepatic Glycogen and Altered Hepatic Hexokinase and Glucokinase Activities in Infected Mice.

Authors:  Rotimi Johnson Ojo; Grace Manmak Paul; Dorcas Dedan Magellan; Dogwo Nahum Dangara; Gideon Gyebi
Journal:  Acta Parasitol       Date:  2022-04-27       Impact factor: 1.534

7.  The Possible Role of Glucose-6-Phosphate Dehydrogenase in the SARS-CoV-2 Infection.

Authors:  Israel Pérez-Torres; María Elena Soto; Verónica Guarner-Lans; Linaloe Manzano-Pech; Elizabeth Soria-Castro
Journal:  Cells       Date:  2022-06-21       Impact factor: 7.666

Review 8.  Immunometabolism and HIV-1 pathogenesis: food for thought.

Authors:  Asier Sáez-Cirión; Irini Sereti
Journal:  Nat Rev Immunol       Date:  2020-08-06       Impact factor: 53.106

9.  HIV-1 Tat and Cocaine Impair Survival of Cultured Primary Neuronal Cells via a Mitochondrial Pathway.

Authors:  Francesca Isabella De Simone; Nune Darbinian; Shohreh Amini; Madesh Muniswamy; Martyn K White; John W Elrod; Prasun K Datta; Dianne Langford; Kamel Khalili
Journal:  J Neuroimmune Pharmacol       Date:  2016-03-31       Impact factor: 4.147

Review 10.  Emerging Role and Characterization of Immunometabolism: Relevance to HIV Pathogenesis, Serious Non-AIDS Events, and a Cure.

Authors:  Clovis S Palmer; Darren C Henstridge; Di Yu; Amit Singh; Brad Balderson; Gabriel Duette; Catherine L Cherry; Joshua J Anzinger; Matias Ostrowski; Suzanne M Crowe
Journal:  J Immunol       Date:  2016-06-01       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.